Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4248029586', 'doi': 'https://doi.org/10.1002/hep.28186', 'title': 'Parallel 17: Hepatitis B: Prevention, Natural History, and Outcomes', 'display_name': 'Parallel 17: Hepatitis B: Prevention, Natural History, and Outcomes', 'publication_year': 2015, 'publication_date': '2015-10-01', 'ids': {'openalex': 'https://openalex.org/W4248029586', 'doi': 'https://doi.org/10.1002/hep.28186'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/hep.28186', 'pdf_url': 'https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.28186', 'source': {'id': 'https://openalex.org/S156174673', 'display_name': 'Hepatology', 'issn_l': '0270-9139', 'issn': ['0270-9139', '1527-3350'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.28186', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5022731052', 'display_name': 'Adrian M. Di Bisceglie', 'orcid': 'https://orcid.org/0000-0002-6075-9305'}, 'institutions': [{'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I47838141', 'display_name': 'Saint Louis University', 'ror': 'https://ror.org/01p7jjy08', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I47838141']}, {'id': 'https://openalex.org/I3189630491', 'display_name': 'Arrowhead Pharmaceuticals (United States)', 'ror': 'https://ror.org/00919v790', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I3189630491']}], 'countries': ['FR', 'US'], 'is_corresponding': False, 'raw_author_name': 'Adrian Di Bisceglie', 'raw_affiliation_strings': ['Foundation, Gilead', 'Project, Retrophin, RxCelerate, Velgene; Grant/ Research Support: Alnylam, Arrowhead, Alpha-', 'Saint Louis University, St. Louis, MO;'], 'affiliations': [{'raw_affiliation_string': 'Foundation, Gilead', 'institution_ids': ['https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Saint Louis University, St. Louis, MO;', 'institution_ids': ['https://openalex.org/I47838141']}, {'raw_affiliation_string': 'Project, Retrophin, RxCelerate, Velgene; Grant/ Research Support: Alnylam, Arrowhead, Alpha-', 'institution_ids': ['https://openalex.org/I3189630491']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030715915', 'display_name': 'M. Lombardero', 'orcid': 'https://orcid.org/0000-0001-5386-5321'}, 'institutions': [{'id': 'https://openalex.org/I170201317', 'display_name': 'University of Pittsburgh', 'ror': 'https://ror.org/01an3r305', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I170201317']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Manuel Lombardero', 'raw_affiliation_strings': ['University of Pitts-burgh, Pittsburgh, PA;'], 'affiliations': [{'raw_affiliation_string': 'University of Pitts-burgh, Pittsburgh, PA;', 'institution_ids': ['https://openalex.org/I170201317']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024156994', 'display_name': 'Jeffrey Teckman', 'orcid': 'https://orcid.org/0000-0002-4870-2621'}, 'institutions': [{'id': 'https://openalex.org/I47838141', 'display_name': 'Saint Louis University', 'ror': 'https://ror.org/01p7jjy08', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I47838141']}, {'id': 'https://openalex.org/I3189630491', 'display_name': 'Arrowhead Pharmaceuticals (United States)', 'ror': 'https://ror.org/00919v790', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I3189630491']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}], 'countries': ['FR', 'US'], 'is_corresponding': False, 'raw_author_name': 'Jeffrey Teckman', 'raw_affiliation_strings': ['Foundation, Gilead', 'Project, Retrophin, RxCelerate, Velgene; Grant/ Research Support: Alnylam, Arrowhead, Alpha-', 'Saint Louis University, St. Louis, MO;'], 'affiliations': [{'raw_affiliation_string': 'Saint Louis University, St. Louis, MO;', 'institution_ids': ['https://openalex.org/I47838141']}, {'raw_affiliation_string': 'Project, Retrophin, RxCelerate, Velgene; Grant/ Research Support: Alnylam, Arrowhead, Alpha-', 'institution_ids': ['https://openalex.org/I3189630491']}, {'raw_affiliation_string': 'Foundation, Gilead', 'institution_ids': ['https://openalex.org/I4210162951']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038949267', 'display_name': 'Lewis R. Roberts', 'orcid': 'https://orcid.org/0000-0001-7885-8574'}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lewis Roberts', 'raw_affiliation_strings': ['Mayo Clinic, Rochester, MN;'], 'affiliations': [{'raw_affiliation_string': 'Mayo Clinic, Rochester, MN;', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043626370', 'display_name': 'Harry L.A. Janssen', 'orcid': 'https://orcid.org/0000-0003-2398-8392'}, 'institutions': [{'id': 'https://openalex.org/I185261750', 'display_name': 'University of Toronto', 'ror': 'https://ror.org/03dbr7087', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I185261750']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Harry Janssen', 'raw_affiliation_strings': ['University of Toronto, Toronto, ON, Canada;'], 'affiliations': [{'raw_affiliation_string': 'University of Toronto, Toronto, ON, Canada;', 'institution_ids': ['https://openalex.org/I185261750']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027689213', 'display_name': 'Sarah Morgan', 'orcid': 'https://orcid.org/0000-0002-7851-9836'}, 'institutions': [{'id': 'https://openalex.org/I170201317', 'display_name': 'University of Pittsburgh', 'ror': 'https://ror.org/01an3r305', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I170201317']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Steven Belle', 'raw_affiliation_strings': ['NIH, Bethesda, MD', 'University of Pitts-burgh, Pittsburgh, PA;'], 'affiliations': [{'raw_affiliation_string': 'University of Pitts-burgh, Pittsburgh, PA;', 'institution_ids': ['https://openalex.org/I170201317']}, {'raw_affiliation_string': 'NIH, Bethesda, MD', 'institution_ids': ['https://openalex.org/I1299303238']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086731147', 'display_name': 'Jeffrey K. Nagle', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'Jay Hoof- Nagle', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}, {'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816', 'https://openalex.org/I4210091810', 'https://openalex.org/I137982388']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035898518', 'display_name': 'Jay H. Hoofnagle', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'Jay Hoofnagle', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}, {'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816', 'https://openalex.org/I4210091810', 'https://openalex.org/I137982388']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044442659', 'display_name': 'Gina Choi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'Gina Choi', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}, {'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816', 'https://openalex.org/I4210091810', 'https://openalex.org/I137982388']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014844940', 'display_name': 'Marina Serper', 'orcid': 'https://orcid.org/0000-0003-4899-2160'}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'Marina Serper', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I4210091810', 'https://openalex.org/I137982388', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}, {'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101957972', 'display_name': 'David E. Kaplan', 'orcid': 'https://orcid.org/0000-0002-3839-336X'}, 'institutions': [{'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'David Kaplan', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816', 'https://openalex.org/I137982388', 'https://openalex.org/I4210091810']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005413209', 'display_name': 'Kimberly A. Forde', 'orcid': 'https://orcid.org/0000-0001-6515-3065'}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'Kimberly Forde', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}, {'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816', 'https://openalex.org/I4210091810', 'https://openalex.org/I137982388']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004470985', 'display_name': 'Gregory J. Gores', 'orcid': 'https://orcid.org/0000-0003-3151-009X'}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'Gregory Gores', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}, {'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816', 'https://openalex.org/I4210091810', 'https://openalex.org/I137982388']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050962688', 'display_name': 'Claire E. Lewis', 'orcid': 'https://orcid.org/0000-0003-1938-9530'}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'Conatus Lewis', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}, {'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816', 'https://openalex.org/I4210091810', 'https://openalex.org/I137982388']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5053662835', 'display_name': 'Richard B. Roberts', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}, {'id': 'https://openalex.org/I4210162951', 'display_name': 'Gilead Sciences (France)', 'ror': 'https://ror.org/05d14ax96', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210162951']}, {'id': 'https://openalex.org/I4210118401', 'display_name': 'Bayer (Switzerland)', 'ror': 'https://ror.org/01qwdc951', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210118401', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}, {'id': 'https://openalex.org/I4210154167', 'display_name': 'Genkyotex (Switzerland)', 'ror': 'https://ror.org/051yjgn28', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210104049', 'https://openalex.org/I4210154167']}, {'id': 'https://openalex.org/I157075465', 'display_name': 'Bristol-Myers Squibb (Germany)', 'ror': 'https://ror.org/032hfv632', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I157075465', 'https://openalex.org/I4210091812']}, {'id': 'https://openalex.org/I4210087111', 'display_name': 'Five Prime Therapeutics (United States)', 'ror': 'https://ror.org/001ms2r47', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210087111']}, {'id': 'https://openalex.org/I4210142028', 'display_name': 'Gilead Sciences (Australia)', 'ror': 'https://ror.org/051j13341', 'country_code': 'AU', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816', 'https://openalex.org/I4210142028']}, {'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}, {'id': 'https://openalex.org/I63256845', 'display_name': 'Fujirebio (Belgium)', 'ror': 'https://ror.org/003dqcp70', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210133530', 'https://openalex.org/I63256845']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}, {'id': 'https://openalex.org/I4210091810', 'display_name': 'Medtronic (United States)', 'ror': 'https://ror.org/00grd1h17', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}, {'id': 'https://openalex.org/I2949033070', 'display_name': 'Medtronic (Ireland)', 'ror': 'https://ror.org/04dyhjr58', 'country_code': 'IE', 'type': 'company', 'lineage': ['https://openalex.org/I2949033070', 'https://openalex.org/I4210091810']}, {'id': 'https://openalex.org/I79576946', 'display_name': 'University of Pennsylvania', 'ror': 'https://ror.org/00b30xv10', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I79576946']}, {'id': 'https://openalex.org/I4210137215', 'display_name': 'Inovio Pharmaceuticals (United States)', 'ror': 'https://ror.org/042s6y882', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210137215']}, {'id': 'https://openalex.org/I4210166400', 'display_name': 'Bayer (France)', 'ror': 'https://ror.org/05cm0es58', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I4210166400', 'https://openalex.org/I67348948']}], 'countries': ['AU', 'BE', 'CH', 'DE', 'FR', 'IE', 'US'], 'is_corresponding': False, 'raw_author_name': 'R Roberts', 'raw_affiliation_strings': ['-Consulting: AbbVie, Bristol Myers Squibb,', 'Bayer Pharmaceuticals, Inovio Phar', 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'Gilead, AbbVie,', 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie'], 'affiliations': [{'raw_affiliation_string': '-Consulting: AbbVie, Bristol Myers Squibb,', 'institution_ids': []}, {'raw_affiliation_string': 'Gilead, AbbVie,', 'institution_ids': ['https://openalex.org/I2948539688', 'https://openalex.org/I4210162951']}, {'raw_affiliation_string': 'Novartis, Bayer, BTG; Grant/Research Support: Gilead, AbbVie', 'institution_ids': ['https://openalex.org/I4210118401', 'https://openalex.org/I1283582996']}, {'raw_affiliation_string': 'Isis Pharmaceuticals, Vertex, Proteosta-sis, Genkyotex, The Alpha-', 'institution_ids': ['https://openalex.org/I4210154167']}, {'raw_affiliation_string': 'Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': ['https://openalex.org/I157075465', 'https://openalex.org/I4210087111', 'https://openalex.org/I4210142028']}, {'raw_affiliation_string': 'GSK, Gilead Sci-ences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune,', 'institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I63256845', 'https://openalex.org/I4210140816', 'https://openalex.org/I4210091810', 'https://openalex.org/I137982388']}, {'raw_affiliation_string': 'ISIS Pharmaceuticals, Tekmira; Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Merck, Medtronic, Novartis, Roche, Janssen, Medimmune', 'institution_ids': ['https://openalex.org/I2949033070']}, {'raw_affiliation_string': 'Gastroenterology, University of Pennsylvania, Philadelphia, PA', 'institution_ids': ['https://openalex.org/I79576946']}, {'raw_affiliation_string': 'Bayer Pharmaceuticals, Inovio Phar', 'institution_ids': ['https://openalex.org/I4210137215', 'https://openalex.org/I4210166400']}, {'raw_affiliation_string': 'Grant/Research Support: Bristol Myers Squibb, ARIAD Phar-maceuticals, BTG, Wako Diagnostics, Inova Diagnostics, Gilead Sciences, Five Prime Therapeutics', 'institution_ids': []}]}], 'countries_distinct_count': 8, 'institutions_distinct_count': 23, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.511526, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 73}, 'biblio': {'volume': '62', 'issue': 'S1', 'first_page': '271A', 'last_page': '273A'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10340', 'display_name': 'Hepatitis B Infection and Treatment', 'score': 0.9856, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10340', 'display_name': 'Hepatitis B Infection and Treatment', 'score': 0.9856, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10351', 'display_name': 'Epidemiology and Management of NAFLD', 'score': 0.9069, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C Infection and Treatment', 'score': 0.9047, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/chronic-hepatitis-b', 'display_name': 'Chronic Hepatitis B', 'score': 0.467334}], 'concepts': [{'id': 'https://openalex.org/C163276114', 'wikidata': 'https://www.wikidata.org/wiki/Q484591', 'display_name': 'Natural history', 'level': 2, 'score': 0.79100573}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5665191}, {'id': 'https://openalex.org/C2776608160', 'wikidata': 'https://www.wikidata.org/wiki/Q4785462', 'display_name': 'Natural (archaeology)', 'level': 2, 'score': 0.4456688}, {'id': 'https://openalex.org/C2776029263', 'wikidata': 'https://www.wikidata.org/wiki/Q131742', 'display_name': 'Hepatitis', 'level': 2, 'score': 0.43377274}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.40249762}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3056022}, {'id': 'https://openalex.org/C95457728', 'wikidata': 'https://www.wikidata.org/wiki/Q309', 'display_name': 'History', 'level': 0, 'score': 0.22374442}, {'id': 'https://openalex.org/C166957645', 'wikidata': 'https://www.wikidata.org/wiki/Q23498', 'display_name': 'Archaeology', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/hep.28186', 'pdf_url': 'https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.28186', 'source': {'id': 'https://openalex.org/S156174673', 'display_name': 'Hepatology', 'issn_l': '0270-9139', 'issn': ['0270-9139', '1527-3350'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/hep.28186', 'pdf_url': 'https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.28186', 'source': {'id': 'https://openalex.org/S156174673', 'display_name': 'Hepatology', 'issn_l': '0270-9139', 'issn': ['0270-9139', '1527-3350'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.59, 'id': 'https://metadata.un.org/sdg/2', 'display_name': 'Zero hunger'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W623947166', 'https://openalex.org/W564062025', 'https://openalex.org/W4322706569', 'https://openalex.org/W4244566834', 'https://openalex.org/W4235137802', 'https://openalex.org/W2502818903', 'https://openalex.org/W2042833942', 'https://openalex.org/W2037532264', 'https://openalex.org/W1994215616', 'https://openalex.org/W1969800110'], 'abstract_inverted_index': {'Background:': [0], 'HBV': [1, 36, 67, 125, 129, 291, 302, 315, 347], 'infection': [2, 68, 348], 'is': [3, 20, 336], 'frequent': [4, 272], 'world-wide': [5], 'and': [6, 29, 41, 72, 77, 91, 127, 142, 189, 217, 226, 269, 355], 'may': [7], 'result': [8], 'in': [9, 57], 'progressive': [10], 'liver': [11], 'disease': [12], 'or': [13, 113, 118, 163, 301], 'HCC.Effective': [14], 'therapies': [15], 'are': [16, 38, 42], 'available': [17, 186], 'but': [18, 334], 'treatment': [19], 'usually': [21], 'reserved': [22], 'for': [23, 34, 140, 145, 157, 161, 257, 357], 'patients': [24], '(pts)': [25], 'with': [26, 65, 110, 296, 345], 'selected': [27], 'biochemical': [28, 76], 'serological': [30], 'profiles': [31], '(phenotypes).Currently,': [32], 'criteria': [33], 'defining': [35], 'phenotype': [37, 173, 181, 228, 274], 'not': [39, 169, 293], 'standardized': [40, 70, 319], 'based': [43, 122, 184, 324], 'upon': [44, 123], 'expert': [45], 'opinion': [46], 'rather': [47], 'than': [48], 'medical': [49], 'evidence.Aim:': [50], 'To': [51], 'determine': [52, 202], 'the': [53, 84, 206, 253, 278, 308], 'distribution': [54, 207], 'of': [55, 61, 80, 101, 208, 214, 240, 280, 290, 314, 330, 343], 'phenotypes': [56, 135, 209, 316], 'a': [58, 172, 180, 338], 'large': [59], 'cohort': [60], 'North': [62], 'American': [63], 'pts': [64, 81, 98, 241, 344], 'chronic': [66, 107, 346], 'using': [69, 151, 164, 229, 317], 'definitions': [71, 320], 'calculation.Methods:': [73], 'Epidemiologic,': [74], 'demographic,': [75], 'virologic': [78], 'features': [79], 'enrolled': [82], 'into': [83, 99, 171], 'HBRN': [85], 'Cohort': [86], 'Study': [87], 'at': [88, 182], '19': [89], 'US': [90], '1': [92, 100], 'Canadian': [93], 'site': [94], 'were': [95, 136, 149, 174, 242], 'analyzed,': [96], 'assigning': [97], '4': [102, 138], 'phenotypes:': [103], 'immune': [104], 'tolerant': [105], '(IT),': [106], 'hepatitis': [108], 'B': [109], '(CHB': [111, 116], 'e+)': [112], 'without': [114], 'HBeAg': [115], 'e-)': [117], 'inactive': [119], 'carrier': [120], '(IC)': [121], 'baseline': [124, 183], 'DNA': [126, 130], 'ALTs.Cut-off': [128], 'values': [131, 154, 188, 286], 'used': [132], 'to': [133, 201, 248, 340, 349], 'define': [134], '10': [137, 143], 'IU/ml': [139], 'e-negative': [141], '5': [144], 'e-positive': [146], 'pts.ALT': [147], 'cut-offs': [148], 'analyzed': [150], 'either': [152], 'fixed': [153, 230], '(30': [155], 'U/L': [156, 160], 'men,': [158], '20': [159], 'women)': [162], 'each': [165], 'local': [166, 177], 'lab': [167], 'ULN.Pts': [168], 'fitting': [170], 'designated': [175, 243], '"Indeterminant".Independently,': [176], 'investigators': [178], 'assigned': [179], 'on': [185, 325], 'laboratory': [187], 'clinical': [190, 273, 312], 'impression.Results:': [191], '1398': [192], 'adults': [193], '(51%': [194], 'male,': [195], '71%': [196], 'Asian)': [197], 'had': [198, 283], 'data': [199], 'needed': [200], 'phenotype.The': [203], 'table': [204], 'shows': [205], 'calculated': [210, 227, 309], 'by': [211, 245, 250], 'two': [212], 'methods': [213], 'assessing': [215], 'ALT': [216, 255, 285], 'physician': [218], 'assessment.Only': [219], 'moderate': [220], 'agreement': [221], 'was': [222, 260, 276], 'found': [223], 'between': [224], 'clinician-determined': [225], 'ALTs': [231], '(Kappa': [232], '0.39,': [233], '95%': [234], 'CI': [235], '0.36-0.42).Of': [236], 'note,': [237], 'only': [238], '13%': [239], 'Indeterminant': [244], 'clinicians': [246], 'compared': [247], '20-40%': [249], 'computer': [251], 'calculation.Using': [252], 'Fixed': [254], 'groups': [256], 'comparison,': [258], 'IT': [259], 'most': [261, 271], 'distinct,': [262], 'being': [263], 'generally': [264], 'younger,': [265], 'more': [266, 350], 'frequently': [267], 'Asian': [268], 'female.The': [270], 'identified': [275], 'Indeterminant,': [277], 'majority': [279], 'whom': [281], '(83%)': [282], 'elevated': [284], 'despite': [287], 'low': [288], 'levels': [289], 'DNA,': [292], 'apparently': [294], 'associated': [295], 'higher': [297], 'BMI,': [298], 'alcohol': [299], 'consumption': [300], 'genotype.Clinician': [303], 'estimates': [304], 'often': [305], 'differed': [306], 'from': [307], 'phenotype.Conclusions:': [310], 'The': [311], 'significance': [313], 'these': [318, 331], 'requires': [321], 'further': [322], 'study': [323], 'long': [326], 'term': [327], 'follow': [328], 'up': [329], 'patient': [332], 'cohorts': [333], 'there': [335], 'clearly': [337], 'need': [339, 356], 're-examine': [341], 'categorization': [342], 'accurately': [351], 'predict': [352], 'their': [353], 'outcomes': [354], 'therapy.': [358]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4248029586', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-08-27T12:03:14.711684', 'created_date': '2022-05-12'}